cp 96345 has been researched along with l 742694 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cascieri, MA; Hale, JJ; MacCoss, M; MacIntyre, DE; Mathre, DJ; Metzger, JM; Mills, SG; Qi, H; Sadowski, S; Shah, SK; Strader, CD | 1 |
1 other study(ies) available for cp 96345 and l 742694
| Article | Year |
|---|---|
2(S)-((3,5-bis(trifluoromethyl)benzyl)-oxy)-3(S)-phenyl-4- ((3-oxo-1,2,4-triazol-5-yl)methyl)morpholine (1): a potent, orally active, morpholine-based human neurokinin-1 receptor antagonist.
Topics: Administration, Oral; Animals; CHO Cells; Cricetinae; Humans; Morpholines; Neurokinin-1 Receptor Antagonists | 1996 |